Cargando…
Daprodustat for anaemia in patients with heart failure and chronic kidney disease: A randomized controlled study
AIMS: Hypoxia‐inducible factor‐prolyl hydroxylase (HIF‐PH) inhibitors have been developed for the treatment of renal anaemia; however, no study has evaluated the safety and efficacy of HIF‐PH inhibitors in patients with heart failure (HF). This study was designed to evaluate the safety and efficacy...
Autores principales: | Iso, Takashi, Matsue, Yuya, Mizukami, Akira, Tokano, Takashi, Isoda, Kikuo, Suwa, Satoru, Miyauchi, Katsumi, Yanagisawa, Naotake, Okumura, Yasuo, Minamino, Tohru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773652/ https://www.ncbi.nlm.nih.gov/pubmed/35983622 http://dx.doi.org/10.1002/ehf2.14109 |
Ejemplares similares
-
Daprodustat: First Approval
por: Dhillon, Sohita
Publicado: (2020) -
Efficacy and safety of daprodustat in Japanese peritoneal dialysis patients
por: Kanai, Hidetoshi, et al.
Publicado: (2021) -
Capture of Part of a Vessel Wall by a Coronary Orbital Atherectomy System
por: Yasuda, Hidetoshi, et al.
Publicado: (2022) -
Coronary lipid-rich plaque characteristics in Japanese patients with acute coronary syndrome and stable angina: A near infrared spectroscopy and intravascular ultrasound study
por: Takahashi, Norihito, et al.
Publicado: (2021) -
An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects
por: Cizman, Borut, et al.
Publicado: (2018)